Clinical Research Directory
Browse clinical research sites, groups, and studies.
LTFU for All Cell and Gene Therapy Studies
Sponsor: AstraZeneca
Summary
Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.
Official title: A LOng-term Follow-up Master Protocol for Participants Who Received Cell or Gene Therapies in Other AstraZeneca StUdieS (LOCUS)
Key Details
Gender
All
Age Range
18 Years - 130 Years
Study Type
OBSERVATIONAL
Enrollment
64
Start Date
2025-09-17
Completion Date
2041-11-29
Last Updated
2025-06-27
Healthy Volunteers
No
Conditions
Interventions
AZD5851
Safety follow-up for up to 15 years of subjects who received AZD5851 in study NCT06084884.
AZD0754
Safety follow-up for up to 15 years of subjects who received AZD0754 in study NCT06267729.
Locations (25)
Research Site
Phoenix, Arizona, United States
Research Site
Duarte, California, United States
Research Site
Orange, California, United States
Research Site
San Francisco, California, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Jacksonville, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Westwood, Kansas, United States
Research Site
Rochester, Minnesota, United States
Research Site
St Louis, Missouri, United States
Research Site
Hackensack, New Jersey, United States
Research Site
New York, New York, United States
Research Site
Columbus, Ohio, United States
Research Site
Portland, Oregon, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
Houston, Texas, United States
Research Site
East Melbourne, Australia
Research Site
Kashiwa, Japan
Research Site
Kyoto, Japan
Research Site
Osakasayama-shi, Japan
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea